Old Web
English
Sign In
Acemap
>
Paper
>
1508TiPDurvalumab in frail and elder patients with stage four NSCLC: The DURATION trial
1508TiPDurvalumab in frail and elder patients with stage four NSCLC: The DURATION trial
2018
J. Kuon
F Bozorgmehr
Martin Schneider
Johannes Krisam
Felix Lasitschka
M. Serke
Wolfgang Schuette
Nicolas Moosmann
W. Gleiber
M. Faehling
M. Wermke
P Schuett
M Boesche
V van Laak
L. Fischer von Weikersthal
M Ulmer
C Meyer zum Büschenfelde
Jr Fischer
Michael Thomas
Keywords:
General surgery
Physical therapy
Medicine
Durvalumab
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]